Amorepacific Shares Plunge 25% Amid Disappointing Q2 Results

Amorepacific, a leading player in the Korean beauty industry, saw its stock plummet nearly 25% following the announcement of its second-quarter earnings, which fell significantly short of market expectations. This decline also resulted in a market capitalization loss of approximately 2.4 trillion KRW (about $2 billion USD).

On the trading day following the earnings release, Amorepacific's shares closed down 24.91% at 124,500 KRW, hitting an intraday low of 123,200 KRW. The company’s market capitalization dropped from 9.7 trillion KRW to 7.3 trillion KRW.

The decline was notably driven by heavy selling from foreign and institutional investors, who sold off 56.7 billion KRW and 140.5 billion KRW worth of shares, respectively. Amorepacific’s preferred stock also saw a significant decline, closing 21.37% lower at 36,600 KRW.

The main culprit behind this dramatic drop in stock price is Amorepacific’s weak financial performance in Q2. The company reported sales of 904.8 billion KRW and an operating profit of 4.2 billion KRW, marking year-over-year declines of 4.3% and 29.5%, respectively.

In response to these results, Korea Investment & Securities lowered its target price for Amorepacific from 240,000 KRW to 200,000 KRW, a 16.7% decrease. Analyst Kim Myung-ju cited underperformance in the Chinese market and disappointing results from subsidiary COSRX as key factors. COSRX’s sales fell slightly to around 143 billion KRW, with operating profit also declining compared to the previous quarter.

Kim explained that a fundamental overhaul of the sales strategy in China led to a significant drop in revenue. Additionally, duty-free sales fell by 25% year-over-year, further impacting the profitability of Amorepacific's domestic operations.

Hyundai Motor Securities analyst Ha Hee-ji also lowered the target price for Amorepacific from 230,000 KRW to 210,000 KRW, forecasting continued challenges through Q3 due to the restructuring of the Chinese subsidiary and weak duty-free sales. Other major securities firms such as Mirae Asset Securities, NH Investment & Securities, Kiwoom Securities, Hana Securities, and Shinhan Investment Corporation also reduced their target prices for the company.

While the recent decline in Amorepacific’s stock price is likely to be short-term, the company’s future performance hinges on the recovery of its Chinese business and improvement in COSRX’s results. The potential for a rebound exists, but it will require strategic adjustments and market recovery in key regions.

Comments

Modamoda's Dye Shampoo: Banned but Eyeing Market Return

Defining Modamoda Shampoo Modamoda Shampoo, launched in Korea in 2021, was designed to naturally dye your hair through regular washing. The product's creator, Modamoda's CEO, was inspired by how bananas darken over time. The shampoo promised to avoid harmful dye ingredients such as PPDA, 5-diamine, and toluene sulfate. Instead, it was marketed as a 'self-coloring' shampoo, offering a fresh approach to hair color. Modamoda's Success Story In just five months, Modamoda generated domestic sales of 32 billion won and international sales of 28 billion won, becoming a sensation. The product's popularity even prompted criticism from rival companies, who accused Modamoda of exaggerated advertising. In March 2022, the company made an agreement with Target to sell their product in about 1900 stores across the U.S. Their success was further confirmed when they topped the Cosmoprof North America Awards 2022, standing out amongst 1,170 hair brands. The Hurdle: THB Ingredie...

The Modamoda Journey: From Safety Controversies to Reinvention

The Meteoric Rise and Subsequent Setback of Modamoda Launched in Korea in 2021, Modamoda Shampoo revolutionized the haircare market with its "self-coloring" formula, achieving billions in both domestic and international sales. But its rapid ascent was interrupted by safety concerns over 1-2-4-THB (1-2-4-trihydroxybenzene), an ingredient restricted by the European Union and scrutinized by food and drug administrations in both Korea and the U.S. due to its potential genotoxic effects. Emerging from the THB Controversy: A Reformulated Approach To navigate the murky waters of regulation, Modamoda returned to the lab. The company designed a new formula excluding THB, focusing on safer ingredients like 'Black Change Complex EX' and 'Polyphenols.' This new formula went through stringent safety verification and even secured an 'Excellent' rating from the German Dermatest. Yet, the new formula has ignited fresh debates, as it includes 'Black 401,' a sy...

Helena Rubinstein: Unveiling the Life and Legacy of a Cosmetics Pioneer

Helena Rubinstein (1872-1965) was more than just a name in the world of beauty; she was a trailblazer who revolutionized the cosmetics industry. From her modest beginnings in Poland to her reign as a global beauty titan, Rubinstein's journey remains an inspiration. Through her brand, Rubinstein pushed boundaries, championing the idea that beauty could be a powerful tool for women's empowerment. From Humble Beginnings to the Cosmetics Throne Helena Rubinstein was born in 1872 in Krakow, Poland. Leaving her homeland at a young age, she initially moved to Australia, where her career in the cosmetics industry began. Rubinstein noticed the harsh effects of the Australian sun on the skin and developed a cream to protect and moisturize it. This innovation led to the launch of Helena Rubinstein's first product, Valaze, a face cream formulated with herbs from the Carpathian Mountains. The success of Valaze was pivotal in Rubinstein's career, propelling her into the global cosme...

Pabby Cosmetics

Search This Blog